Improvement in fibrosis without worsening steatohepatitis was observed in 36.8% of semaglutide recipients versus 22.4% of those receiving placebo (difference: 14.4%
Prospects of GLP-1 Therapies for Addiction and Mental Health ComorbiditiesQuo Vadis
Studies have shown that regular semaglutide use can help in losing 5-10% of body weight over 3-6 months
A plethora of other gut released peptides exist to be explored: Amylin [46] , peptide YY (PYY) [47] , Cholecystokinin (CCK), secretin, neurotensin, somatostatin (SST) and ghrelin to name a few
If dining out, review restaurant menus in advance to identify suitable options
Handle according to laboratory storage, sterility, and documentation requirements